NDC 72934-2096

HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%

Hyaluronic Acid Sodium Salt 1% / Niacinamide 4% / Tacrolimus 0.1%

HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sinceru Florida, Llc. The primary component is Tacrolimus; Niacinamide; Hyaluronic Acid.

Product ID72934-2096_874bbbd4-1245-2867-e053-2995a90a8593
NDC72934-2096
Product TypeHuman Prescription Drug
Proprietary NameHYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1%
Generic NameHyaluronic Acid Sodium Salt 1% / Niacinamide 4% / Tacrolimus 0.1%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSinceru Florida, LLC
Substance NameTACROLIMUS; NIACINAMIDE; HYALURONIC ACID
Active Ingredient Strength0 g/100g; g/100g; g/100g
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2096-2

30 g in 1 BOTTLE, PUMP (72934-2096-2)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2096-2 [72934209602]

HYALURONIC ACID SODIUM SALT 1% / NIACINAMIDE 4% / TACROLIMUS 0.1% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
TACROLIMUS.1 g/100g

Pharmacological Class

  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]
  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.